| Typicality: | 0.214 |
| Saliency: | 0.122 |
| because of adverse effects | 3 | cause |
| therapy → be discontinued in → approximately 5% of patients | 3 |
| therapy → be discontinued in → approximately 3% of patients | 3 |
| negative | neutral | positive |
| 0.786 | 0.207 | 0.007 |
| Raw frequency | 6 |
| Normalized frequency | 0.122 |
| Modifier score | 0.500 |
| Perplexity | 22.657 |